PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2012–2015

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2015	—	3	1
2014	—	4	1
2013	—	4	1
2012	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CAPITOL HILL CONSULTING GROUP	—	13

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	11
SENATE	11
Food & Drug Administration (FDA)	4
Defense, Dept of (DOD)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	12
Defense	Defense	2
Chemicals/Chemical Industry	Chemicals/Chemical Industry	1
Science/Technology	Science/Technology	1
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	1
Health Issues	Health Issues	1
Government Issues	Government Issues	1
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bills Explicitly Cited (20)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 1406114th Congress

Saving Access to Compounded Medications for Special Needs Patients Act

2015 · second_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to PL 113-54, The Drug Quality and Security Act Issues related to agriculture appropriations and defense appropriations. Issues related to S. 1406 - saving access to compound medications for special needs patients act.

Client expense: — · Firm income: $60,000

Matched citations: S. 1406

H.R. 3089113th Congress

Compounding Clarity Act of 2013

2014 · fourth_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.3089

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · fourth_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · fourth_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: S.959

Show 16 more cited filings

H.R. 3089113th Congress

Compounding Clarity Act of 2013

2014 · third_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.3089

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · third_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: H.R.3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · third_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: S.959

H.R. 3089113th Congress

Compounding Clarity Act of 2013

2014 · second_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: HR 3089

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · second_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: HR 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · second_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act

Client expense: — · Firm income: $50,000

Matched citations: S.959

H.R. 3089113th Congress

Compounding Clarity Act of 2013

2014 · first_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act

Client expense: — · Firm income: $45,000

Matched citations: HR 3089

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · first_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act

Client expense: — · Firm income: $45,000

Matched citations: HR 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · first_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act

Client expense: — · Firm income: $45,000

Matched citations: S. 959

H.R. 3089113th Congress

Compounding Clarity Act of 2013

2013 · fourth_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)

Client expense: — · Firm income: $45,000

Matched citations: HR 3089

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · fourth_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)

Client expense: — · Firm income: $45,000

Matched citations: HR 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2013 · fourth_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)

Client expense: — · Firm income: $45,000

Matched citations: S. 959

H.R. 3089113th Congress

Compounding Clarity Act of 2013

2013 · third_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)

Client expense: — · Firm income: $45,000

Matched citations: HR 3089

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · third_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)

Client expense: — · Firm income: $45,000

Matched citations: HR 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2013 · third_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)

Client expense: — · Firm income: $45,000

Matched citations: S. 959

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2013 · second_quarter · Firm: CAPITOL HILL CONSULTING GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Compounding pharmacy and FDA issues Pharmaceutical Compounding Quality and Accounting Act (S. 959)

Client expense: — · Firm income: $45,000

Matched citations: S. 959

Source: Senate LDA

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA — Lobbying Disclosure | Poliscope